In addition, Bet has been effectively used as a treatment agent for patients with inherited genetic disorders related to HHcy, such as cystathionine β-synthase deficiency and methylene tetrahydrofolate reductase deficiency [43]. This evidence concerns the gene PPIB and hereditary disease.